Back to funds

Merck & Co., Inc.

institutionalUpdated 9 days ago

Managed by Merck & Co., Inc. • Latest filing Q3 2026

Portfolio value
$820.3M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$276.3M
Q1 2026$349.4M
Q2 2026$526.4M
Q3 2026$820.3M

Top holdings

13 positions as of Q3 2026

View filing
M

MODERNA INC

Value
$444.5M
Shares
2.31M
% Port
54.18%
P

PERSONALIS INC

Value
$228.7M
Shares
14.04M
% Port
27.87%
K

KYMERA THERAPEUTICS INC

Value
$86.3M
Shares
772.2K
% Port
10.52%
A

AKTIS ONCOLOGY INC

Value
$18.6M
Shares
952.8K
% Port
2.26%
E

EIKON THERAPEUTICS INC

Value
$13.4M
Shares
1.67M
% Port
1.63%
T

ENTRADA THERAPEUTICS INC

Value
$11M
Shares
1.74M
% Port
1.35%
A

ALECTOR INC

Value
$6.6M
Shares
3.55M
% Port
0.80%
?
8.N/A

SUTRO BIOPHARMA INC

Value
$4.4M
Shares
272.4K
% Port
0.53%
E

EVAXION AS

Value
$4M
Shares
1.21M
% Port
0.49%
V

VIRIDIAN THERAPEUTICS INC

Value
$1.9M
Shares
93.4K
% Port
0.23%
?
11.N/A

XILIO THERAPEUTICS INC

Value
$959K
Shares
106.0K
% Port
0.12%
?
12.N/A

TUHURA BIOSCIENCES INC

Value
$41K
Shares
19.4K
% Port
0.01%
N

NEUPHORIA THERAPEUTICS INC

Value
$36K
Shares
10.0K
% Port
0.00%

Explore